Transcatheter valve implantation for aortic and tricuspid valve regurgitation:A case report
Transcatheter aortic valve implantation(TAVI)is an important alternative in treating high-risk patients with aortic valve regurgitation.Transcatheter tricuspid valve implantation(TTVI)is also an important treatment option for high-risk patients with tricuspid regurgitation.We reported a 72-year male patient who underwent TAVI due to severe aortic valve regurgitation using a J-Valve.During a two-year follow-up,the patient developed secondary tricuspid regurgitation to atrial fibrillation,and subsequently received TTVI using a LuX-Valve.Following the interventions,the patient's symptoms were significantly improved,and echocardiography indicated good hemodynamic performance of both transcatheter heart valves.This case highlights the feasibility and effectiveness of performing multiple valve implantations via transcatheter approaches in high-risk elderly patients.
NETL
NSTL
万方数据
